Terms of Use

Effective Date: 12-Dec-2024

Last Updated: 30-Jun-2025

This Terms of Use agreement governs your use of the PillPal mobile application ("App") and services. By downloading or using PillPal, you agree to these terms.

1. Licensed Application End User License Agreement (EULA)

1.1 This app uses Apple's Standard EULA for iOS applications. You can review the full terms of that agreement here.

2. Subscription Plans and Pricing

2.1 PillPal offers auto-renewable subscription plans to access premium features:

• Personal Plan:
• £9.99 per month
• £120 per year
• Family Plan:
• £19.99 per month
• £189.99 per year

2.2 All prices are in GBP and inclusive of applicable taxes.

3. Subscription Terms

3.1 Payment will be charged to your Apple ID account upon confirmation of purchase.

3.2 Subscriptions auto-renew unless canceled at least 24 hours before the end of the current period.

3.3 Your account will be charged for renewal within 24 hours prior to the end of the current period.

3.4 You can manage or cancel subscriptions in your Apple Account Settings at any time.

3.5 Unused portions of any free trial period will be forfeited when a subscription is purchased.

4. Use of the App

4.1 You are granted a non-transferable license to use PillPal on any Apple-branded device that you own or control, under the terms of the Apple Standard EULA and in accordance with Apple's Usage Rules.

5. External Services Disclaimer

5.1 PillPal uses WhatsApp to deliver medication reminders. WhatsApp is a third-party platform and has its own privacy policy. PillPal is not affiliated with, endorsed by, or sponsored by WhatsApp or Meta Platforms.

6. Data and Privacy

6.1 Your use of the app is also subject to our Privacy Policy, which explains how we collect, use, and protect your personal information.

7. Termination

7.1 We may suspend or terminate your access to the app if you violate these Terms. You may stop using the service at any time by canceling your subscription.

8. Contact Information

If you have any questions, contact us: